Douglas Dieterich, MD
Articles
February 16th 2017
Treating Medicaid Patients With Hepatitis C: Clinical and Economic Impact
Zobair Younossi, MD Stuart C. Gordon, MD Aijaz Ahmed, MD Douglas Dieterich, MD Sammy Saab, MD Rachel Beckerman, PhD
Hepatitis C virus treatment is often restricted in Medicaid patients. This analysis evaluates the clinical and cost impacts of treating all Medicaid patients versus the current status quo.
May 3rd 2016
Real-World Outcomes of Ledipasvir/Sofosbuvir in Treatment-Naïve Patients With Hepatitis C
Zobair M. Younossi, MD, MPH, FACG, AGAF, FAASLD Haesuk Park, PhD Stuart C. Gordon, MD John R. Ferguson Aijaz Ahmed, MD Douglas Dieterich, MD Sammy Saab, MD, MPH
In the treatment of hepatitis C virus, the gap between efficacy and real-world effectiveness narrows with improved tolerability and ease of use.
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: November 21st 2024 | Updated: November 23rd 2024
Polygenic Risk Scores Can Identify Patients Who Should Receive IOP-Lowering Treatment
